Celsion Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Imunon Inc (IMNN)
Assess today's live Imunon Inc (IMNN) share price, performance and insights using our live NASDAQ: IMNN stock exchange data.
Analyse the historical data and Imunon Inc share price performance charts on this page. Our technical summary section provides analysis on Imunon share price buy/sell indicators using real-time data (or discuss the Imunon (IMNN) stock price today with other investors in the Imunon NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMNN share price (ISIN: US15117N7012) to enhance your trading decisions with our free investment tools and resources.
What Is the Imunon Inc Share Price Today?
The Imunon share price today is 2.8000.
What Is the Stock Symbol for Imunon Inc
The stock symbol (or 'ticker') for Imunon Inc is "IMNN."
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Imunon Inc share price performance charts on this page. Our technical summary section provides analysis on Imunon share price buy/sell indicators using real-time data (or discuss the Imunon (IMNN) stock price today with other investors in the Imunon NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ IMNN share price (ISIN: US15117N7012) to enhance your trading decisions with our free investment tools and resources.
What Is the Imunon Inc Share Price Today?
The Imunon share price today is 2.8000.
What Is the Stock Symbol for Imunon Inc
The stock symbol (or 'ticker') for Imunon Inc is "IMNN."
What Stock Exchange Does Imunon Inc Trade On?
Imunon Inc is listed and trades on the NASDAQ stock exchange.
Is Imunon Inc a Good Stock to Buy?
Determining whether Imunon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7650
2.9895
52 wk Range
2.5200
41.2174
IMNN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.76502.9895
52 wk Range
2.520041.2174
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMNN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.2000
Upside
+585.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company’s lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Imunon Inc Earnings Call Summary for Q4/2025
- Imunon reported 22% improvement in net loss to $14.5M ($6.83/share) vs $18.6M in 2024, driven by disciplined cost management and R&D reductions.
- R&D expenses fell to $7.8M following OVATION 2 study completion; company holds $8.8M cash with runway extending into H2 2026.
- Company actively seeking strategic financing for pivotal OVATION 3 trial; OVATION 2 results showed promising overall survival data for ovarian cancer.
- Stock trades near 52-week low at $2.88 (-79% YoY) with $9.86M market cap; analysts maintain Strong Buy rating with $12-$33 price targets.
- Management expressed confidence in IMNN-001's potential despite cash burn concerns; clinical success critical for future funding and regulatory approvals.
Last Updated: 31/03/2026, 17:10
Read Full TranscriptCompare IMNN to Peers and Sector
Metrics to compare | IMNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −1.5x | −0.5x | |
PEG Ratio | −0.01 | −0.02 | 0.00 | |
Price/Book | 1.6x | 1.1x | 2.6x | |
Price / LTM Sales | - | 13.2x | 3.2x | |
Upside (Analyst Target) | - | 131.2% | 47.4% | |
Fair Value Upside | Unlock | 8.8% | 6.9% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.2000
(+585.71% Upside)
Earnings
Latest Release
31/03/2026
EPS / Forecast
-1.45 / -0.23
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Imunon (NASDAQ: IMNN) Share Price Today?
The Imunon stock price today is 2.8000 USD.
What Stock Exchange Does Imunon (IMNN) Trade On?
Imunon is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Imunon?
The stock symbol (also called a 'ticker') for Imunon is "IMNN."
What Is the Current Imunon Market Capitalisation?
As of today, Imunon (NASDAQ: IMNN) market cap is 10.9800M USD.
What Is Imunon's (IMNN) Earnings Per Share (TTM)?
The Imunon EPS is currently -6.8265 (Trailing Twelve Months).
When Is the Next Imunon Earnings Date?
Imunon's next earnings report will be released on 13/11/2025.
Is IMNN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Imunon moving averages and other technical indicators, the daily buy/sell signal for IMNN stock is Strong Sell.
How Many Times Has Imunon Stock Split?
Imunon has split 5 times. (See the IMNN stock split history page for full effective split date and price information.)
How Many Employees Does Imunon Have?
Imunon has 25 employees, based on their latest Companies House report.
What is the current trading status of Imunon (NASDAQ: IMNN)?
As of 28/04/2026, Imunon (IMNN) is trading at a share price of 2.8000 USD, with a previous close of 2.8000 USD. The stock has fluctuated within a day range of 2.7650 USD to 2.9895 USD, while its 52-week range spans from 2.5200 USD to 41.2174 USD.
What Is Imunon (IMNN) Price Target According to Analysts?
The average 12-month price target for Imunon is 19.2000 USD, with a high estimate of 33 USD and a low estimate of 10 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +585.71% Upside potential.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.